Work

A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia

Year: 2016

Type: article

Abstract: Chronic myelomonocytic leukemia (CMML) is a hematopoietic stem cell neoplasm with features of both myelodysplasia and myeloproliferation.[1] Cytopenias and progression to acute myeloid leukemia (AM...

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.3109/10428194.2016.1138295

Authors: Srinivas K. Tantravahi, Philippe Szankasi, Jamshid S. Khorashad, Kim-Hien Dao, Tibor Kovacsovics, Todd W. Kelley, Michael W. Deininger

Institutions: University of Utah, Huntsman Cancer Institute, ARUP Laboratories (United States), OHSU Knight Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Celgene, National Heart, Lung, and Blood Institute

Award: G596604889

OpenAlex ID: W2239916430

FWCI: 1.846

Cites: 16

Cited by: 26

Related to: 10